Risk of symptomatic leishmaniasis in patients with inflammatory bowel disease receiving biologic therapy in an endemic Mediterranean region: a population-based case-control study.
- DOI
- 10.1093/ecco-jcc/jjag067
- Published
- 2026 Jun 7
- Container
- Journal of Crohn's & colitis
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ecco-jcc/jjag067,
title = {Risk of symptomatic leishmaniasis in patients with inflammatory bowel disease receiving biologic therapy in an endemic Mediterranean region: a population-based case-control study.},
author = {Gimeno-Pitarch L and Iborra M and Crespo A and Sanchis L and Antón MR and Pastor M and Martí L and Herreros B and Peña C and Ruíz L and Almudena Pérez A and Díaz FC and Maroto N and Laveda R and Madero L and Buendía L and Nos P},
year = {2026},
journal = {Journal of Crohn's \& colitis},
doi = {10.1093/ecco-jcc/jjag067},
url = {https://doi.org/10.1093/ecco-jcc/jjag067}
}RIS
TY - JOUR TI - Risk of symptomatic leishmaniasis in patients with inflammatory bowel disease receiving biologic therapy in an endemic Mediterranean region: a population-based case-control study. AU - Gimeno-Pitarch L AU - Iborra M AU - Crespo A AU - Sanchis L AU - Antón MR AU - Pastor M AU - Martí L AU - Herreros B AU - Peña C AU - Ruíz L AU - Almudena Pérez A AU - Díaz FC AU - Maroto N AU - Laveda R AU - Madero L AU - Buendía L AU - Nos P PY - 2026 JO - Journal of Crohn's & colitis DO - 10.1093/ecco-jcc/jjag067 UR - https://doi.org/10.1093/ecco-jcc/jjag067 ER -
APA
L, G., M, I., A, C., L, S., MR, A., M, P., L, M., B, H., C, P., L, R., A, A. P., FC, D., N, M., R, L., L, M., L, B., & P, N. (2026). Risk of symptomatic leishmaniasis in patients with inflammatory bowel disease receiving biologic therapy in an endemic Mediterranean region: a population-based case-control study.. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjag067
Source records
- pubmed · retrieved 2026-09-25T11:35:59.395Z